Globavend is trading 5% up at $1.08, with the catalyst remaining uncertain.

  • No clear company-specific announcement or filing dated August 26, 2026 explains the move.
  • The latest identified disclosure was an August 12 share-count update, merely updated on August 26.
  • Nasdaq is down 0.15% and the S&P 500 is down 0.02%; the gain may reflect stock-specific trading activity.